Company News 13 Jul 2026 Orthocell delivers record quarterly and full-year revenue as global commercial momentum accelerates Orthocell (ASX:OCC) has released its Quarterly Report for the quarter ended 30 June 2026, reporting record quarterly and full-year revenue, continued… Orthocell
Company News 03 Jul 2026 Orthocell Appoints Exclusive Remplir™ Distributor for Thailand Orthocell Limited (ASX: OCC) has appointed medical device distributor MediTime as its exclusive distributor for Remplir™ in Thailand, following regulatory… Orthocell
Company News, Video 24 Jun 2026 Orthocell featured in AusBiotech Spotlight series Orthocell has been featured in AusBiotech’s Spotlight series, which profiles organisations and individuals contributing to Australia’s life sciences sector. Orthocell
Company News 20 Jun 2026 2026 Nerve Symposium Now in its fourth year, the Orthocell Nerve Symposium has become an important forum for advancing discussion, education and practical… Orthocell
Company News 10 Jun 2026 Surgical Solutions for Peripheral Nerve Repair Dinner & Lecture Orthocell hosted the Surgical Solutions for Peripheral Nerve Repair Dinner & Lecture in Perth this evening, proudly supported by our… Orthocell
Company News 30 Apr 2026 Orthocell achieves first Remplir™ sales in US$75 million Canadian Market Orthocell has shared that it has completed the first commercial sales of Remplir™ in Canada, marking a key milestone in… Orthocell
Company News 28 Apr 2026 Remplir™ RWE study delivers 90% success rate Orthocell has announced compelling new data from its ongoing Remplir™ Real World Evidence (RWE) study, demonstrating strong and consistent clinical outcomes across a broad… Orthocell
Company News 20 Apr 2026 Orthocell reports continued growth and strong US momentum in March 2026 quarter Orthocell (ASX:OCC) has released its Quarterly Report for the quarter ended 31 March 2026, highlighting continued revenue growth, strong commercial… Orthocell
Company News 17 Apr 2026 First Remplir™ Surgical Case Completed in U.S. Department of Defense Hospital Network Orthocell has shared that the first surgical case using Remplir™ has been successfully completed within the U.S. Department of Defense (DoD) / Veterans… Orthocell
Company News 15 Apr 2026 Orthocell secures Remplir™ approval across U.S. Department of Defence Hospital Network Orthocell has secured approval for Remplir™ to be used across the United States Department of Defence and Veterans Affairs (VA) hospital networks, marking a significant… Orthocell
